08:30 – 10:00 hrs | Concurrent Symposia S09-12 & Educational Sessions E09-E10
S09.1 4D Nucleome project
Sheng Zhong;
United States
S09.2 Functional organization of the nuclear envelope
Ohad Medalia;
Switzerland
S09.3 3D genome organisation in disease
Juanma Vaquerizas;
Germany
S10.1 From association to causal variant(s): statistical methods for finemapping
Christian Benner;
Finland
S10.2 Taking it further: trans-ethnic association analysis accounting for ancestry increases power for discovery and improves fine-mapping resolution
Andrew Morris;
United Kingdom
S10.3 Large scale integration of genetic and ‘omics’ data to find susceptibility genes for complex traits
Sara Pulit;
Netherlands
S11.1 De novo variants in neurodevelopmentals disorders with epilepsia
Johannes Lemke;
Germany
S11.2 Parental Mosaicism in “De Novo” Epileptic Encephalopathies
Heather Mefford;
United States
S11.3 Somatic mutations of the mTOR pathway in focal epilepsies
Stephanie Baulac;
France
S12.1 Genetic heterogeneity in CDG: where are the patients?
Gert Matthijs;
Belgium
S12.2 CDG therapies
Eva Morava;
United States
S12.3 Link between Golgi ion homeostasis defects and Congenital Disorders of Glycosylation
Francois Foulquier;
France
E09.1 p53 mutational scanning
Eran Segal;
Israel
E09.2 Dissecting protein sequence function using Deep Mutational Scans
Lea Starita;
United States
E10.1 Title to be announced
Simon Myers;
United Kingdom
E10.2 Mutagenic recombination
Irene Tiemann-Boege;
Austria
10:00 – 10:30 hrs | Coffee Break, Exhibition, Poster Viewing
10:15 – 11:15 hrs | Poster Viewing with Authors – Group C
11:15-12:45 hrs | Corporate Satellites
11:15-12:45 hrs | Lunch Break, Exhibition, Poster Viewing
13:00 – 14:30 hrs | Concurrent Sessions C13-C18 from submitted abstracts
14:30 – 15:00 hrs | Fruit Break, Exhibition, Poster Viewing
15:00-16:30 hrs | Workshops W12-W18
More information to follow.
More information to follow.
More information to follow.
More information to follow.
More information to follow.
More information to follow.
More information to follow.
15:00-16:30 hrs | Corporate Satellites
16:30 – 17:00 hrs | Coffee Break, Exhibition, Poster Viewing
16:45 – 17:45 hrs | Poster Viewing with Authors – Group D
17:45 – 19:15 hrs | Concurrent Symposia S13-S16 & Educational Sessions E11-E12
S13.1 Understanding mutational processes
Núria López-Bigas;
Spain
S13.2 Finding a germline mutation during tumor testing: implications for the patient and the family
Jeffrey Weitzel;
United States
S13.3 Liquid biopsy to follow clonal evolution in cancer
Benedetta Mussolin;
Italy
S14.1 Introduction
Vivienne Parry;
United Kingdom
S14.2 Genetics and Social Media
Ellen Matloff;
United States
S14.3 CRISPR Babies: Our Cells/Ourselves
Francoise Baylis;
Canada
S15.1 Enhancer Logic and Mechanics in Development and Disease.
Ali Shilatifard;
United States
S15.2 Regulation of disease-associated gene expression in the 3D genome
Wouter De Laat;
Netherlands
S15.3 Identifying DNA-regulatory elements in non-traditional model systems
David Garfield;
Germany
S16.1 Partitioning complex trait heritability into functional and tissue-specific categories using LD score regression
Hilary Finucane;
United States
S16.2 Genetic instruments in mendelian randomization studies
George Davey-Smith;
United Kingdom
S16.3 Large-scale inference of human genetic data
Manuel Rivas;
United States
E11.1 Title to be announced
Speaker to be announced ;
E11.2 Title to be announced
Speaker to be announced ;
E12.1 Systematic analysis of genetic interactions: from yeast to human
Jolanda Van Leeuwen;
Switzerland
E12.2 Epistasis in Cardiac defects
Bart Loeys;
Belgium